Drugs
PHOENIX, AZ: $58.3 Million in Net Revenue Versus $29.2 Million in Q3 2013; Cash, Cash Equivalents, and Investments Up at the End of Quarter to $89.5 Million ...
FOSTER CITY, CA: 2014 EPS Guidance Revised Upward; ZADAXIN(R) Leads Continued Growth of Core Business in 2014 ...
WAKEFIELD, MA: Companies Struggling to Develop ASN/Paper Solutions Internally or with 3PL Providers Now Have Streamlined and More Affordable Path to Meet January 1 Deadline ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 11/10/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the independent Data and Safety Monitoring Board (DSMB) charged with periodically rev ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/07/14 -- . (OTCBB: TTNP) today announced that it will host a live conference call at 11 a.m. EST / 8 a.m. PST on Friday, Nov. 14, 2014 to discuss the co ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/06/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that new data from an ongoing Phase 1/2 trial evaluating TH-302 and low-dose dex ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 11/06/14 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, will release its third quarter 2014 fi ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 11/06/14 -- Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan a ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/05/14 -- Theravance, Inc. (NASDAQ: THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at t ...
MANCHESTER, NH: According to CDC, There Are 86 Million People in the U.S. That Have Elevated Blood Glucose Levels; According to the IDF, There Are 382 Million People Worldwide Living With Elevated Blood Sugar and Tha ...
LYON, FRANCE: Vazculep(TM) Is Now Shipping to Hospitals in All Three Vial Sizes; David Monteith Joins as Vice President, Research and Development; Conference Call With Management to Take Place at 10:00 am ET on Oct ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/30/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its US operati ...
SOUTH SAN FRANCISCO, CA: William H. Waltrip Appointed Chairman of the Board Effective October 30, 2014; Announces Fourth Quarter Cash Dividend of $0.25 per Share; Theravance to Host Conference Call and Webcast Today at 5:00 p ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 10/30/14 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2014 on Monday, November ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 10/28/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the Company will release its financial results for the third quarter 2014 on Tuesday, November ...
SAN FRANCISCO, CA and JOHANNESBERG, SOUTH AFRICA: SAN FRANCISCO, CA and JOHANNESBERG, SOUTH AFRICA -- (Marketwired) -- 10/28/14 -- Serenus Biotherapeutics, Inc., a specialty biopharmaceutical company bridging the divide between the world's lead ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/28/14 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has invested C ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwired) -- 10/24/14 -- On October 20, 2014, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Retrophin, In ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/23/14 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended September 30, 2014 after market clo ...
NEWARK, DE: NEWARK, DE -- (Marketwired) -- 10/22/14 -- iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC (N ...
